Updated Jul 16, 2026
Bharucha David is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $158K.
David Bharucha is the Chief Medical Officer at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing etripamil for cardiovascular treatments. He has experience in the medical field, particularly in drug development and clinical trials.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | S — Open-market sale | 12.2K | $1.93 | $24K |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | M — Option exercise | 20.1K | — | |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | S — Open-market sale | 58.0K | $2.32 | $135K |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | A — Grant or award | 100.0K | — | |
| 2025-07-11 | MIST | Milestone Pharmaceuticals Inc. | A — Grant or award | 53.3K | — |
David Bharucha is the Chief Medical Officer at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing etripamil for cardiovascular treatments. He has experience in the medical field, particularly in drug development and clinical trials.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($158K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bharucha David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.